This topic contains a solution. Click here to go to the answer

Author Question: An inhibitory postsynaptic potential can be the result of a. chloride ions (Cl-) entering the ... (Read 135 times)

nummyann

  • Hero Member
  • *****
  • Posts: 576
An inhibitory postsynaptic potential can be the result of
 
  a. chloride ions (Cl-) entering the somatodendritic regions of a postsynaptic neuron
  b. potassium ions (K+) exiting the somatodendritic regions of a postsynaptic neuron
  c. either of these
  d. neither of these

Question 2

What is the difference between a competitive antagonist and an inverse agonist?
 
  What will be an ideal response?



Related Topics

Need homework help now?

Ask unlimited questions for free

Ask a Question
Marked as best answer by a Subject Expert

sierramartinez

  • Sr. Member
  • ****
  • Posts: 313
Answer to Question 1

c

Answer to Question 2

A competitive antagonist binds to the same receptors as an agonist but has little or no capability of activating the receptors, thus, reducing the potential activity of the agonist. An inverse agonist is a drug that binds to the receptor, but stimulates intrinsic activity opposite of neurotransmitter.




nummyann

  • Member
  • Posts: 576
Reply 2 on: Jun 22, 2018
Thanks for the timely response, appreciate it


isabelt_18

  • Member
  • Posts: 342
Reply 3 on: Yesterday
:D TYSM

 

Did you know?

The most common treatment options for addiction include psychotherapy, support groups, and individual counseling.

Did you know?

In 1886, William Bates reported on the discovery of a substance produced by the adrenal gland that turned out to be epinephrine (adrenaline). In 1904, this drug was first artificially synthesized by Friedrich Stolz.

Did you know?

It is widely believed that giving a daily oral dose of aspirin to heart attack patients improves their chances of survival because the aspirin blocks the formation of new blood clots.

Did you know?

Certain topical medications such as clotrimazole and betamethasone are not approved for use in children younger than 12 years of age. They must be used very cautiously, as directed by a doctor, to treat any child. Children have a much greater response to topical steroid medications.

Did you know?

For pediatric patients, intravenous fluids are the most commonly cited products involved in medication errors that are reported to the USP.

For a complete list of videos, visit our video library